Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)

Ozyurek E. S. , Yoldemir T. , Artar G.

JOURNAL OF OVARIAN RESEARCH, cilt.10, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: We aimed to test the hypothesis that the correlation of the changes in the blood Androstenedione (A(4)) levels to the number of selected follicles during ovulation induction with low-dose recombinant human follicle stimulating hormone (rhFSH) is as strong as the correlation to changes in the blood Estradiol (E-2) levels in polycystic ovary syndrome (PCOS).